VSRV yields 2000000.06% · JNJ yields 2.13%● Live data
📍 VSRV pulled ahead of the other in Year 1
Combined, VSRV + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VSRV + JNJ for your $10,000?
Voiceserve, Inc., through its subsidiaries, engages in developing, manufacturing, licensing, and supporting a range of voice over Internet protocol (VoIP) software products and services for various types of communication devices in Europe, North America, Asia, and internationally. It provides VoipSwitch, an Internet protocol telephony system offering services, such as device to phone technology, personal computer (PC) to phone/Web to phone features, calling cards, SMS/ANI/PIN/DID/WEB callback, DIDs' mapping, and call shops; Videoswitch, a video on demand platform for delivering online content to various screens ranging from smartphones and PCs to high definition home theatres; and Call-to-PBX, which offers voice, video, and mobile IP communications solutions for small-to-medium size businesses and residential customers. The company markets its products and services to VoIP wholesalers termination carriers, retail VoIP providers, Internet providers, including WiFi and WiMax operators, cable TV networks, GSM providers, telecom resellers, prepaid serve companies, and small-to-medium size companies. Voiceserve, Inc. was founded in 2002 and is based in Edgware, the United Kingdom.
Full VSRV Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.